Markets:

Overview

News

Currencies

International

Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ:XRAY)

11.21 -0.07 (-0.62%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

DENTSPLY SIRONA INC. (NASDAQ: XRAY) INVESTOR ALERT: Investors With Large Losses in DENTSPLY SIRONA Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

December 02, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Rosen Law Firm Urges Dentsply Sirona Inc. (NASDAQ: XRAY) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

November 27, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA

November 27, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

The Latest Analyst Ratings For Dentsply Sirona ↗

October 28, 2024

Via Benzinga

Navigating 6 Analyst Ratings For Dentsply Sirona ↗

October 08, 2024

Via Benzinga

Analyst Expectations For Dentsply Sirona's Future ↗

September 20, 2024

Via Benzinga

NASDAQ: XRAY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm

November 15, 2024

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Crude Oil Rises 1%; US Jobless Claims Increase To 221,000 ↗

November 07, 2024

Via Benzinga

Gold Gains 1%; Halliburton Posts Weak Q3 Results ↗

November 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 07, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Dentsply Sirona Through 10 Analysts ↗

July 18, 2024

Via Benzinga

Evaluating Dentsply Sirona: Insights From 8 Financial Analysts ↗

June 25, 2024

Via Benzinga

Key Takeaways From Dentsply Sirona Analyst Ratings ↗

May 06, 2024

Via Benzinga

Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand ↗

November 07, 2024

Dentsply Sirona Q3 earnings beat estimates, but a $495M goodwill impairment and lowered sales outlook cause stock to drop 22%.

Via Benzinga

Topics Earnings

Tesla To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday ↗

October 28, 2024

Via Benzinga

Critical Insights From Dentsply Sirona Analyst Ratings: What You Need To Know ↗

August 20, 2024

Via Benzinga

Dentsply Sirona Misses Q2 Targets - Plans Restructuring Plan Amid Weak Demand ↗

July 31, 2024

Dentsply Sirona misses Q2 earnings, announces restructuring amid weak demand.

Via Benzinga

XRAY Stock Earnings: Dentsply Sirona Misses EPS, Misses Revenue for Q2 2024 ↗

July 31, 2024

XRAY stock results show that Dentsply Sirona missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts ↗

April 18, 2024

Via Benzinga

Demystifying Dentsply Sirona: Insights From 4 Analyst Reviews ↗

February 29, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Evaluating Dentsply Sirona: Insights From 8 Financial Analysts ↗

January 09, 2024

Via Benzinga

XRAY Investors Have the Opportunity to Join Investigation of DENTSPLY SIRONA Inc. with the Schall Law Firm

June 26, 2024

From The Schall Law Firm

Via Business Wire

$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying ↗

June 04, 2024

Via Benzinga

7 Long-Term Stocks to Buy Now: May 2024 ↗

May 22, 2024

While anything can happen in the markets from day to day, over the long-term, these seven long-term stocks to buy should prosper regardless.

Via InvestorPlace

DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY

May 10, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results ↗

May 02, 2024

Via Benzinga

Dentsply Sirona Falls Over 4% Following Q1 Results - Read Why ↗

May 02, 2024

Dentsply Sirona's Q1 disappoints with revenue miss at $953M, down 2.6% YoY; adjusted EPS meets expectations at 42 cents.

Via Benzinga

XRAY Stock Earnings: Dentsply Sirona Meets EPS, Misses Revenue for Q1 2024 ↗

May 02, 2024

XRAY stock results show that Dentsply Sirona met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Sustaining Growth Momentum: Dentsply Sirona Continues to Excel and Reports Rising Profits ↗

January 12, 2024

As the day concludes, Dentsply Sirona (NASDAQ:XRAY) is preparing to distribute a dividend payout of $0.14 per share, resulting in an annualized dividend yield of 1.65%. This payout is exclusive to...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DENTSPLY SIRONA Inc. - Common Stock (NQ:XRAY)

All News about DENTSPLY SIRONA Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today